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Abstract
Background: In an effort to ensure that all physicians have access to valid and reliable evidence
on drug effectiveness, the Italian Drug Agency sponsored a free-access e-learning system, based on
Clinical Evidence, called ECCE. Doctors have access to an electronic version and related clinical
vignettes. Correct answers to the interactive vignettes provide Continuing Medical Education
credits. The aims of this trial are to establish whether the e-learning program (ECCE) increases
physicians' basic knowledge about common clinical scenarios, and whether ECCE is superior to the
passive diffusion of information through the printed version of Clinical Evidence.
Design: All Italian doctors naïve to ECCE will be randomised to three groups. Group one will have
access to ECCE for Clinical Evidence chapters and vignettes lot A and will provide control data for
Clinical Evidence chapters and vignettes lot B; group two vice versa; group three will receive the
concise printed version of Clinical Evidence. There are in fact two designs: a before and after
pragmatic trial utilising a two by two incomplete block design (group one versus group two) and a
classical design (group one and two versus group three). The primary outcome will be the retention
of Clinical Evidence contents assessed from the scores for clinical vignettes selected from ECCE at
least six months after the intervention. To avoid test-retest effects, we will randomly select
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vignettes out of lot A and lot B, avoiding repetitions. In order to preserve the comparability of lots,
we will select vignettes with similar, optimal psychometric characteristics.
Trial registration: ISRCTN27453314
Background
Continuing Medical Education for health professionals
In the last decade many countries have legislated within
their health systems the revalidation and recertification of
medical practitioners [1]. Two principles underlie Contin-
uing Medical Education (CME): professional develop-
ment is a process of lifelong learning in practice, and
professionals must be able to demonstrate they are clini-
cally competent in certain roles. Many countries are facing
the challenge of building a formal, sustainable assessment
of skills through education programs, accredited provid-
ers, acquisition of credit points, and voluntary or manda-
tory regulation[1]. Although it has been claimed that CME
should also include managerial, psychosocial and com-
munication skills to reflect the multidisciplinary context
of patient care[2], usually professional development is
mainly based principally on advanced clinical subjects.
Traditional knowledge transfer formats employ live inter-
active classes supported by paper-based text and graphic
materials; online learning is increasing popular, sup-
ported by screen-based text and graphics with different
levels of interactivity.
CME in Italy
A compulsory system of CME was introduced in Italy for
all health professionals in 1998. During the five-year cycle
from 2002 to 2006, health professionals have been
required to earn a total of 150 credits [3]. A national edu-
cation committee defines the educational standards,
accredits educational events, and sets the number of cred-
its earned. A credit involves one hours' learning, i.e., one
hour of education is worth one credit, but there is a
weighting towards activities that present evidence-based
(EB) information and are free of commercial interests. The
traditional form of acquiring CME credits is to attend lec-
tures and conferences; it is more rare for doctors to be
exposed to small group interactive events. Between 2004
and 2005, the committee approved and evaluated the pro-
vision of distant learning programmes: 136,208 health
professionals (46,952 doctors, 34%) earned 737,603
credits, a result welcomed as a large success [4].
Dissemination of independent information in Italy
In an effort to ensure that all physicians have open access
to valid and reliable evidence on drug effectiveness and
safety, the Italian Drug Agency (AIFA) launched a pro-
gram to disseminate independent, unbiased information.
The agency did this by translating into Italian Clinical Evi-
dence, a compendium of the best available evidence on
treating a wide range of common conditions (Figure 1),
and freely distributing it. By 2006, the fourth Italian edi-
tion (based on Clinical Evidence, Vol. 14) had been pub-
lished. The online version is freely available to all
practicing 248,000 doctors, and 47,000 general practi-
tioners (GPs) receive also a free copy of the concise ver-
sion of the book.
Interest in EB health care is growing in Italy, although its
impact upon clinical practice is still not clear. In 1999, the
first pilot free distribution of 50,000 copies of Clinical Evi-
dence  was assessed through a survey exploring doctors'
judgement of its validity, relevance, and usability. The
findings indicated that the compendium had been well-
received, and confirmed doctors' preference for problem-
driven information and the key role of strong endorse-
ment from health authorities for its implementation [5].
Clinical Evidence Figure 1
Clinical Evidence.
Clinical Evidence (http://www.clinicalevidence.com/) has specific features that make it different 
from traditional textbooks and practice guidelines[30]:  
x its contents are driven by practical questions rather than by the availability of evidence 
x it aims not to make recommendations but to inform on the best available evidence 
x it highlights rather than hides gaps in research evidence 
x it is continuously updated.  
According to its website, Clinical Evidence “describes the best available evidence from systematic 
reviews, RCTs [randomized controlled trials], and observational studies where appropriate, and if 
there is no good evidence it says so.” Implementation Science 2008, 3:37 http://www.implementationscience.com/content/3/1/37
Page 3 of 11
(page number not for citation purposes)
However, another survey funded by the Smith Kline Foun-
dation showed that Italian GPs were satisfied with the
information provided by pharmaceutical sales representa-
tives, who they considered complete and sufficiently reli-
able [6].
In order to make certain it was worth the expense of dis-
seminating Clinical Evidence and to speed up the diffusion
of EBM, AIFA sponsored a free-access e-learning system,
based on Clinical Evidence, called ECCE (the Italian acro-
nym for Continuing Education Clinical Evidence). ECCE
became accessible to all physicians in March 2005 after a
pilot period. The results of the first year of use (until Feb-
ruary 2006) are reported in detail elsewhere and summa-
rised in Figure 2[7].
The potential role of e-learning from transferring 
information to modifying clinical practice
Several conceptual models have been developed for
assessing knowledge and competence. A popular one pro-
posed by Miller identifies four stages of development:
'knows, knows how, shows how, and does' that are the
essential facets of clinical competence [8]. An individual
progresses through cognitive and behavioural steps, from
acquiring knowledge to performing a task in practice.
Miller's theory assumes that competence predicts per-
formance. Other proposed models consider other influ-
ences on a doctor's performance [9], including system-
related factors (government incentives, guidelines) and
individual-related ones (patient's expectation, relation-
ship with peers) with increasing levels of complexity.
For the purposes of this trial we will adopt Miller's simpler
model. The stages of development have been slightly
changed to better reflect the different components and
skills targeted by educational interventions focusing on
EBM: 1) factual knowledge or basic learning: knowing the
benefits and risks of different interventions (e.g., in
patients with unstable angina, aspirin is beneficial); 2)
deep learning or competence: posing structured clinical
questions considering patients, treatment, comparison,
and outcomes and understanding quantitative aspects
(relative or absolute risk reduction, number needed to
treat); 3) point-of-care ability or performance: the incor-
poration of EB information into practice, with the adop-
tion of proven treatments and interventions that can
potentially improve patients' health. The modified EBM
Miller's model is shown in Figure 3.
ECCE is thought to directly affect superficial learning
(ability to reproduce facts) and, with decreasing impact,
deep learning (ability to apply concepts and skills in the
workplace) [10]. ECCE's impact on clinical behaviour and
patients' outcomes is less straightforward: we prefer to
adopt a conservative framework considering phases that
necessarily follow one another [11]. Therefore, in this
study we want first and foremost to show an improve-
ment in physicians' knowledge, which may or may not
affect competence and, finally, on behaviours and
patients' outcomes.
Aim of the study
This trial will test the effectiveness of ECCE e-learning pro-
gram for transferring EB information to medical doctors
after a median of three months of ECCE usage, and reten-
Use and average respondents' opinions of ECCE by registered doctors [7] Figure 2
Use and average respondents' opinions of ECCE by registered doctors[7].
 
  Use   Opinion   
Are ECCE vignettes: 
Yes 
% (n) 
Total physicians registered* 19 340      Relevant*  93.6 (232 994) 
Users logged in  18 003 (93.1%)     Appropriate for educational 
purposes* 
95.8 (232 994) 
Clinical vignettes        Free of commercial interests*  84.5 (232 994) 
  - Undertaken  244 624      Easy to use*  92.9 (150 231) 
- Successfully 
completed 
215 412 
(88.1%) 
  Have you got new information?  76.0 (152 965) 
- At first attempt  170 969 
(69.9%) 
  Do you intend to use this information 
in your practice? 
93.3 (155 080) 
Total CME credits provided 292 058 
  
 
*Registered at 28 February 2006;  
Users logged in: at least one case attempted 
Total physicians in practice: 248 000; general practitioners: 47 000. Implementation Science 2008, 3:37 http://www.implementationscience.com/content/3/1/37
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tion of the information after a median period of six
months. The main hypotheses to be tested are: 1) Does an
e-learning CME program based on Clinical Evidence and
clinical vignettes (ECCE) increase physicians' basic
knowledge about epidemiology, therapy, prognosis, and
risk factors in a clinical scenario? 2) Do physicians retain
the knowledge from the ECCE for more than six months?
3) Is this educational intervention superior to the passive
diffusion of information through the printed version of
Clinical Evidence?
The secondary hypotheses are: Does ECCE modify physi-
cians' attitudes to EB behaviours in a simulated realistic
clinical scenario?
Methods
ECCE: An E-learning CME Program
ECCE is an e-learning CME tool that uses interactive clin-
ical vignettes based on chapters in Clinical Evidence and a
predefined sequence of questions. ECCE has four compo-
nents: 1) the Clinical Evidence chapter (e.g., headache,
chronic tension-type); 2) a clinical vignette from the Clin-
ical Evidence chapter that presents a plausible medical sce-
nario (e.g., Margaret says to her family doctor: "This time
I didn't come for me, but to talk about Rachel, my 25-year-
old daughter....); 3) questions addressing the recall of
Clinical Evidence facts or their application to the medical
scenario, from which the doctor is to select the correct
answer; 4) the potential answers (e.g., a list of potential
efficacy descriptors for a therapeutic regimen relevant to
the theme); and 5) instructions on what to do (e.g., "more
than one answer may be correct").
Figure 4 gives an example of a vignette from ECCE. The
response option includes one or more correct answers for
each question, and other reasonably plausible but incor-
rect response as distractors.
Vignettes are intended to replicate real-life circumstances
as seen by an ordinary GP in everyday practice. Whilst GPs
are the primary target of ECCE, many vignettes are also
relevant to specialists. Each vignette has a narrative with
events and clinical details presented in chronological
order: the history evolves with new information from
diagnostic tests or additional information reported by the
patient. All vignettes use news media techniques, some-
times with fictional or interactive elements (e.g., mystery
fiction, the possibility to order tests and obtain results in
real time, test appropriateness and cost). Users solve the
single steps though a question and answer decision sys-
tem. They gain credits upon completing all steps where
they reach a score of 80% or more of the total. Vignettes
Miller's model modified to consider different steps of knowledge, competence and performance of EBM Figure 3
Miller's model modified to consider different steps of knowledge, competence and performance of EBM. In this 
model, the learning ability of ECCE decreases from knowledge to performance (in yellow).Implementation Science 2008, 3:37 http://www.implementationscience.com/content/3/1/37
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Example of an ECCE vignette Figure 4
Example of an ECCE vignette. We present the first step of the headache (chronic tension-type) vignette and related ques-
tions. The vignette was developed from Headache (chronic tension-type), Clinical Evidence.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Margaret says to her family doctor: “This time I didn’t come for me, but to talk about Rachel, 
my 25-year-old daughter. As you probably remember, she got married last year; unfortunately, 
she doesn’t seem to get along well with her husband... Anyway, the other day she told me that 
in the past few months she has often suffered from headache; I’m quite worried about that, you 
know what I have been through...” The doctor remembers very well that many years before 
Margaret, one of his first patients, was always complaining about her headache, a pain that 
tormented her all the time and was not relieved by analgesics. He tells Margaret to come back 
with her daughter. After a few days the two women are in the doctor’s office. Rachel says: 
“This headache is killing me. I have it every day now, sometimes with nausea. And I don’t want 
to take analgesics anymore, they don’t do me any good”. She describes her pain as a bilateral 
tight, “bandlike” discomfort: “My head feels as if it is in a vice. Following the advice of a friend 
of mine I have also tried to take some drops of a benzodiazepine; but the headache didn’t go 
away, and I felt drowsy and light-headed”. Rachel looks very pale, tired and tense. Examining 
her the doctor doesn’t find anything abnormal; he suspects a chronic tension-type headache, 
and prescribes a battery of blood tests. 
 
According to the studies identified by Clinical Evidence, in Rachel's case 
benzodiazepines: 
x may be very effective, but only in the short term 
x may be effective, but only in the long term 
x benzodiazepines may be useful only in people with very severe headache 
x may induce a modest short term improvement, but are often associated with adverse 
effects 
x are contraindicated 
 
Answer: may induce a modest short-term improvement, but are often associated with adverse 
effects. 
 Implementation Science 2008, 3:37 http://www.implementationscience.com/content/3/1/37
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provide one or two credits depending on the number of
questions. Users are required to finish the vignette started
regardless of the score reached. If a user fails, the vignette
is then not used again for 24 hours. In 2005, we posted
120 vignettes, and in 2006, 52 new ones.
Both clinical vignettes and related questions will be care-
fully planned against Clinical Evidence chapters by ECCE
authors who are all specialised medical practitioners.
Standardised guidelines will be developed by the ECCE
editors to help authors. Author guidelines will consider
system rules (i.e., each question has five multiple-choice
answers), writing style (avoid misleading constructs such
as double negatives), medical style (avoid excessive tech-
nical jargon, such as rigor nucalis) and provide an example
framework. Each vignette will be revised by two editors to
ensure it is appropriate for the Clinical Evidence chapter
tested. All vignettes will be copy-edited to high editorial
standards. Although this would be a highly standardised
process, a skilled clinical vignette writer is essential for
valid assessment of doctors' abilities and competencies
[12].
ECCE has all the standard advantages of e-learning. Users
select what and when they want to learn, and at what pace.
The system is easy to use and works with basic computer
requirements (e.g., low speed connection). The contents
of Clinical Evidence can be read on-screen or printed and
interactively managed along the steps of each vignette.
The system tracks learning content and the learner's
progress.
Study design
This is a before and after pragmatic randomised control-
led trial utilising a two-by-two incomplete block design.
When evaluating educational interventions aimed at
improving clinical practice, a number of non-specific
effects may influence estimates of the effect of an interven-
tion, grouped together under the term Hawthorne effect
[13-17]. These include positive attention effects, caused
by participants knowing that they are the subject of a
study, but also negative and demotivating effects, caused
by being allocated to a control rather than an intervention
group. If these non-specific effects are imbalanced across
study groups in a quality improvement trial, the estimates
may be biased. Randomised controlled trials using bal-
anced incomplete block designs should balance such non-
specific effects [13,15,17-20].
Because the Hawthorne effect may influence the outcome,
this trial will adopt a two-by-two balanced incomplete
block design in which subjects will be randomised into
two groups. Group one will have access to ECCE for Clin-
ical Evidence chapters and vignettes lot A and will provide
control data for Clinical Evidence chapters and vignettes lot
B. Group two will have access to ECCE for lot B and will
provide control data for lot A. The design will be balanced
because it ensures that all participants receive the same
intensity of educational intervention and data collection,
which should therefore balance any non-specific effects.
The design will be incomplete because not all participants
receive the complete education for all chapters and
vignettes [14,17]. To check for a possible Hawthorne
effect we will add a third control arm (classical design),
with only a minimal intervention consisting of one of the
elements of the complete intervention, namely the con-
cise printed version of Clinical Evidence and access to the
on-line full-text version. This group will not have access to
the ECCE platform nor the clinical vignettes related to
Clinical Evidence. The incomplete block design will answer
Table 1: Designs, hypotheses per trial, and possibility of ensuring equal Hawthorne effect across the arms.
Trial comparison Design Hypothesis Hawthorne
Arm I vs. II Complete intervention on lot A. Using lot B 
as control.
Block If the test scores related to lot A vignettes increase in 
accordance with Clinical Evidence chapters A and there is no 
change in test scores of B chapters, the intervention has a 
genuine effect.
No
Arm II vs. I Complete intervention on lot B. Using lot A 
as control.
Block If the test scores related to lot B vignettes increase in 
accordance with Clinical Evidence chapters B and there is no 
change in test scores of A chapters, the intervention has a 
genuine effect.
No
Arm I vs. III Complete intervention for lot A (ECCE). 
Minimal intervention on A-B chapters (Clinical Evidence) 
(control).
Classical If the test scores related to A vignettes in the intervention arm 
increase in accordance with the Clinical Evidence chapters A and 
there is no change in the control arm the intervention (ECCE) 
has a favourable effect, but without controlling for the 
Hawthorne effect.
Yes
Arm II vs. III Complete intervention for lot B (ECCE). 
Minimal intervention on A-B chapters (Clinical Evidence) 
(control).
Classical If the test scores related to lot B vignettes in the intervention 
arm increase in accordance with the Clinical Evidence chapters B 
and there is no change in the control arm the intervention 
(ECCE) has a favourable effect, but without controlling for the 
Hawthorne effect.
YesImplementation Science 2008, 3:37 http://www.implementationscience.com/content/3/1/37
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the question "Does ECCE increase physicians' basic
knowledge about EB information," while the classical
design will answer the question "Is ECCE superior to the
printed version of Clinical Evidence." Table 1 summarises
the block and the classical designs.
Equivalence of clinical vignettes
We will develop two comparable lots of clinical vignettes
focusing on different medical topics. In order to preserve
comparability we will select vignettes with similar, opti-
mal psychometric characteristics [21-23]. They will be
ranked for the following psychometric properties: validity
of users' judgement, content validity, internal consistency,
and responsiveness.
To avoid contamination, we will make sure that the
vignettes in lots A and B are different so that learning
about the management of lot A conditions does not influ-
ence management of lot B conditions. For example, there
may be contamination if lot A focuses on ischemic heart
disease (and highlights the need to optimize diabetes con-
trol in diabetics) and lot B focuses on diabetes (and high-
lights the need to optimize control of ischemic heart
disease risk factors).
The authors will analyse the cumulative profile of the psy-
chometric characteristics of each vignette and will select
valid, reliable, and distinct vignettes. These will then be
balanced to the intervention arms to have two compara-
ble lots, avoiding contamination. The flow of vignette
selection through the different phases is presented in Fig-
ure 5. We cannot estimate how many vignettes will reach
the threshold for validity and reliability to be considered
appropriate. We will stop selection only when we have at
least six appropriate vignettes for the two ECCE arms in
the incomplete block design.
Study participants
This study will involve Italian doctors naïve to ECCE who
voluntarily agree to participate. Doctors can learn about
this research program through advertisements in medical
journals and websites. New users who enter the ECCE
website will be automatically invited to participate. There
will be no exclusion criteria.
Allocation to experimental arms
The Italian Cochrane Centre will produce the computer
algorithm for the allocation sequence and will implement
it on ECCE. Once doctors agree to participate, ECCE will
assign doctors to one of the three arms using a balanced
randomisation scheme. Researchers will be unable to
manipulate the randomisation sequence or interfere with
the ECCE registration process. In Figure 6, we present a
flow chart outlining the progress of participants through
the study. This protocol follows the recommendations of
the Consort Statement [Additional file 1] [24].
Intervention
Doctors randomised to ECCE will have access to their
clinical vignettes for three months after enrolment, or
until they finish all vignettes. All participants will have a
logbook to indicate how many times they accessed the
The flow of vignette selection through the different phases Figure 5
The flow of vignette selection through the different phases.
Vignettes selected for 
formal assessment of 
psychometric characteristics Assessment of: 
xPsychometric 
characteristics (user 
judgement, content 
validity, internal 
consistency and 
responsiveness) 
xContamination risks
Vignettes with high-
rank psychometric 
characteristics 
Lot A 
at least 6 vignettes
Valid and reliable 
Creation of two 
balanced, 
uncontaminated lots 
Lot B 
at least 6 vignettes 
valid and reliable  Implementation Science 2008, 3:37 http://www.implementationscience.com/content/3/1/37
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platform and how much time they spent solving clinical
vignettes. Doctors randomised to receive a printed copy of
Clinical Evidence may use it as much as they want over the
whole trial period and may have access to the on-line ver-
sion of Clinical Evidence. The ECCE platform will always
be inaccessible to them during the intervention period.
After the intervention period, a sample of contamination-
controlled clinical vignettes will be accessible to arm 1
and 2 participants until the end of the trial.
Outcomes measures and measurements
The primary outcome will be basic knowledge of the Clin-
ical Evidence contents assessed through the scores from the
clinical vignettes. The test will consist of fixed and multi-
ple-choice questions from the selected valid, reliable
vignettes and will be administered before (pre-test),
immediately after (approximately 16 weeks after enrol-
ment, post-test one), and six months after the interven-
tion (approximately 36 weeks after enrolment, post-test
two) (see Figure 6).
To reduce the risk of a test-training effect (practice effects
or memory of the first administration will influence post-
test performance) at each test section ('pre-test', 'post-test
one' and 'post-test two'), we will randomly select two
vignettes from lot A and two from lot B to avoid repeti-
tion. Therefor, each participant will have only a limited
probability (approximately zero) of test/re-testing the
same vignette from one assessment to another. The ques-
tionnaire will investigate the same Clinical Evidence
knowledge for intervention and control chapters. This
random sampling of outcomes with high psychometric
standards will eliminate any interactions between the
causal relationship and the classes of outcomes studied or
not studied within the same group of vignettes [25]. To
prevent participants from guessing which vignettes will be
evaluated, we will add a number of "distracter" vignettes
to lots A and B. All groups will also rate their satisfaction
with the information source and its perceived value for
their medical education and clinical practice.
The flow of participants through the different trial steps Figure 6
The flow of participants through the different trial steps.Implementation Science 2008, 3:37 http://www.implementationscience.com/content/3/1/37
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Study procedures and data collection
The three arms will complete a pre-activity demographic
survey, the knowledge tests, and surveys of participation
at other educational events. There is growing recognition
of EBM in Italy and independent educational initiatives to
improve general practice are becoming more common.
During the trial, this additional education could be an
important threat to internal validity. We will record these
concurrent educational experiences in our sample and
assess their effects in exploratory post hoc analyses.
Data will be collected from all participants using online
instruments. The ECCE platform will manage and track all
data collection, following up by e-mail the participants
after 16 and 36 weeks. Although researchers are not
blinded for the trial group allocation, they will not be able
to interfere in collection.
The demographic survey will record sex, age, and years of
practice; practice characteristics; preferred CME format;
computer skills; ease in using the Internet; familiarity with
EB information; frequency of attending residential and
distant CME activities.
Sample size and calculation of power
Based on a preliminary examination of test scores, we
established that the smallest useful difference for this
intervention was a 20% absolute improvement. Based on
a preliminary test of 300 doctors, we found that a 28%
absolute improvement was due to the intervention. We
standardised the absolute improvement across different
type of vignettes (five or ten questions). Therefore we cal-
culated our sample size to detect a 0.7 standardized differ-
ence in the primary outcome, set the α error rate at 0.05
(two-sided), and the β error at 0.10 (90% power). This
yielded a sample size of 45 practitioners per study arm. If
the accrual period is six months, and the maximum fol-
low-up period is six months with a loss during follow-up
of 20% at the end of the study, the total number of prac-
titioners to be randomised has been adjusted upwards to
162 (54 per intervention group).
Statistical analyses
Knowledge test data will be analysed using repeated-
measure analyses of variance (ANOVA), reporting the par-
tial omega squared (ù2) effect size with corresponding
95% confidence interval. Scores for the    knowledge test
scale will be subjected totwo-by-three [TO TWO-BY-
THREE] repeated-measures ANOVA having: 1) one
between-subjects factor (ECCE lot A and ECCE lot B) and
one within-subject factor (pre-test, post-test one and post-
test two) for the incomplete block design trial; 2) one
between-subjects factor (ECCE set and control) and one
within-subject factor (pre-test, post-test one and post-test
two) for the classical trial. Tests of Sidak-adjusted simple
main effects will be used for post-hoc mean comparisons
as needed. Orthogonal planned contrasts will be formu-
lated for the knowledge test data to verify knowledge
retention. We do not expect the data sets to follow normal
distributions and assumptions completely. If this is the
case, we will do nonparametric and robust analyses to
explore differences in medians or distributional shapes. If
nonparametric analysis yields similar interpretations and
conclusions, we will focus on the parametric results.
Additional analyses will include examination of the rela-
tionship between knowledge test outcomes and potential
moderator variables including sex, age, and years of prac-
tice, speciality (e.g., general internal medicine versus gen-
eral surgery); preferred CME format; computer skills; ease
using the internet; familiarity with and readiness to use EB
information; study drop-out; satisfaction with learning
experience, and frequency of attending residential and
distant CME activities. For these analyses, we will use par-
ametric methods (regression, repeated-measures ANOVA,
analyses of covariance (ANCOVA)) and nonparametric
methods (Wilcoxon-Mann-Whitney test, χ2 test of inde-
pendence and γ measure of association) as needed, based
on the data. Holm's modified Bonferroni corrections will
be applied to check experimental error (e.g., in explora-
tory analyses). Analyses will be done based on an inten-
tion-to-treat basis, whether or not doctors logged and
took credits. We will restrict the explanatory analysis to
those doctors who took credits. All the analyses will con-
sider p = 0.05 as significant (two-sided).
SAS version 9.0 statistical software (SAS Institute, Inc,
Cary NC) will be used.
Ethical approval
The study has been approved by the Research Ethics Board
Azienda Sanitaria Locale "Città di Milano", Milano (file
number 43-06 SO) and the participating institutions (Ital-
ian Drug Agency, the Mario Negri Institute for Pharmaco-
logical Research and the Italian Cochrane Centre). This
study is funded by a grant from the Italian Drug Agency, a
government agency that aims to provide credible, impar-
tial advice, and EB information about the effectiveness of
drugs. The Italian Drug Agency approved the design and
the methods but had no role in its conduct, analysis, inter-
pretation, or reporting, and will not have access to the
data. This trial is completely independent from the BMJ
Publishing Group, which publishes the original version of
Clinical Evidence.
Discussion
This protocol of an incomplete block design randomised
control trial aims to determine the effect of a large-scale
online educational intervention using vignettes based on
Clinical Evidence. The educational intervention, ECCE,Implementation Science 2008, 3:37 http://www.implementationscience.com/content/3/1/37
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comprises of:Clinical Evidence, the source of the content;
clinical vignettes as the educational model; the e-learning
tool as information and test vehicle. Our implementation
of these elements may reduce the generalizability of this
intervention. In addition, differences in the CME system
regulation, the availability CME programmes, and access
to EB health care information are likely to increase the dif-
ferences in many industrialized countries. However, other
elements favour the transferability of ECCE: the world-
wide diffusion and appreciation of Clinical Evidence,
including the standardization of its contents and of the
clinical vignettes, its basic computer requirements, and
the low cost for each credit provided.
A recent randomised controlled trial tested an internet-
based CME program compared with a live course [26]. A
cholesterol guideline package was delivered in these two
ways and the trial assessed the long-term outcomes.
Knowledge immediately before and 12 weeks after the
intervention was assessed. The percentage of high-risk
patients who had appropriate lipid panel screening and
pharmacotherapy according to guidelines was docu-
mented with chart audits. Both interventions produced
similar and significant 12-week knowledge gains. Chart
audits indicated high baseline screening rates in all
patient groups (93%) with no significant post-interven-
tion change. However, the internet-based intervention
was associated with a significant increase in the percent-
age of high-risk patients treated with drugs according to
cholesterol guidelines. Our trial does not consider behav-
ioural outcomes because this would be rather compli-
cated due to the large number and types of diseases
considered in each Clinical Evidence chapter. It is clearly
easier to measure an educational intervention designed to
change a single behaviour than one targeting general
management of conditions or patients. In particular, with-
out evidence of prior efficacy or knowledge, it may be
injudicious and precipitous to consider behavioural out-
comes. Indeed, our trial's positive results may reflect phy-
sicians' competence more than appropriate clinical
practice. The teaching properties of case histories are
known [27-29], and in a recent study vignette scores
appeared to be highly correlated to physicians' practice in
outpatient settings and were a valid overall measure of the
care provided [30]. Furthermore, one of the greatest barri-
ers to reading Clinical Evidence was boredom. If our inter-
vention is effective, the written case simulation will turn
the passive reading into a more interactive experience in
which doctors search for the right information for specific
situations, increasing their knowledge.
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